Home Other Building Blocks Pibrentasvir

Pibrentasvir

CAS No.:
1353900-92-1
Catalog Number:
AG01E6LY
Molecular Formula:
C57H65F5N10O8
Molecular Weight:
1113.1802
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG01E6LY
Chemical Name:
Pibrentasvir
CAS Number:
1353900-92-1
Molecular Formula:
C57H65F5N10O8
Molecular Weight:
1113.1802
MDL Number:
MFCD30747902
IUPAC Name:
methyl N-[(2S,3R)-1-[(2S)-2-[6-[(2R,5R)-1-[3,5-difluoro-4-[4-(4-fluorophenyl)piperidin-1-yl]phenyl]-5-[6-fluoro-2-[(2S)-1-[(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamate
InChI:
InChI=1S/C57H65F5N10O8/c1-29(77-3)49(67-56(75)79-5)54(73)70-19-7-9-47(70)52-63-41-25-35(37(59)27-43(41)65-52)45-15-16-46(72(45)34-23-39(61)51(40(62)24-34)69-21-17-32(18-22-69)31-11-13-33(58)14-12-31)36-26-42-44(28-38(36)60)66-53(64-42)48-10-8-20-71(48)55(74)50(30(2)78-4)68-57(76)80-6/h11-14,23-30,32,45-50H,7-10,15-22H2,1-6H3,(H,63,65)(H,64,66)(H,67,75)(H,68,76)/t29-,30-,45-,46-,47+,48+,49+,50+/m1/s1
InChI Key:
VJYSBPDEJWLKKJ-NLIMODCCSA-N
SMILES:
COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1[nH]c2c(n1)cc(c(c2)[C@H]1CC[C@@H](N1c1cc(F)c(c(c1)F)N1CCC(CC1)c1ccc(cc1)F)c1cc2[nH]c(nc2cc1F)[C@@H]1CCCN1C(=O)[C@H]([C@H](OC)C)NC(=O)OC)F)[C@H](OC)C
UNII:
2WU922TK3L
Properties
Complexity:
2000  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
8  
Defined Bond Stereocenter Count:
0
Exact Mass:
1112.491g/mol
Formal Charge:
0
Heavy Atom Count:
80  
Hydrogen Bond Acceptor Count:
17  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0
Molecular Weight:
1113.201g/mol
Monoisotopic Mass:
1112.491g/mol
Rotatable Bond Count:
17  
Topological Polar Surface Area:
200A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
7.4  
Literature
Title Journal
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir. Antimicrobial agents and chemotherapy 20170501
Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. Journal of virology 20080801
Properties